MIRA INFORM REPORT

 

 

Report No. :

302313

Report Date :

12.01.2015

 

IDENTIFICATION DETAILS

 

Name :

ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED (w.e.f.12.10.2007)

 

 

Formerly Known As :

ZYDUS MAYNE ONCOLOGY PRIVATE LIMITED

 

 

Registered Office :

Plot No.3, Pharmez, Special Economic Zone, Sarkhej Bavla Highway, (N. H. No.8-A), Village Matoda, Taluka Sanand – 382210, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

13.06.2005

 

 

Com. Reg. No.:

04-046246

 

 

Capital Investment / Paid-up Capital :

Rs.150.000 Millions

 

 

CIN No.:

[Company Identification No.]

U24230GJ2005PTC046246

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

AHMZ00175A

 

 

PAN No.:

[Permanent Account No.]

AAACZ2327A

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of Pharmaceutical Products.

 

 

No. of Employees :

260  (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (63)

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a joint venture between Cadila Healthcare Limited and Hospira Australia Pty Limited.

 

It is an established company having fine track record. Financial position of the company is sound. Fundamentals of the company’s are strong and healthy.

Trade relations are fair. Business is active. Payments are reported to be regular and as per commitment.

 

The company can be considered good for normal business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long Term = (AA-)

Rating Explanation

High Degree of Safety and Very Low Credit.

Date

12.05.2014

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Jayesh Patel

Designation :

Senior Finance Manager

Contact No.:

91-2717-663000

Date :

08.01.2015

 

 

LOCATIONS

 

Registered Office / Factory :

Plot No.3, Pharmez, Special Economic Zone, Sarkhej Bavla Highway, (N. H. No.8-A), Village Matoda, Taluka Sanand – 382210, Gujarat, India

Tel. No.:

91-2717-663000/ 663211 / 106

Mobile No.:

91-9724307940 (Mr. Jayesh Patel)

Fax No.:

91-2717-663100

E-Mail :

contact@zydushospira.com

jayeshpatel@zydushospira.com

contact@zydusmayne.com

Area :

3866 Sq. Mt.

Location :

Leased

 

 

DIRECTORS

 

As on 01.08.2014

 

Name :

Mr. Omprakash R. Arya

Designation :

Managing Director

Address :

12, Ishan Apartments, Brahmin Mitra Mandal Society, Ellisbridge, Ahmedabad – 380006, Gujarat, India

Date of Birth/Age :

01.03.1950

Qualification

M. Sc.

Experience :

34 years

Date of Appointment :

01.02.2006

DIN No. :

00146677

Voter ID No.:

IIE 1621093

 

 

Name :

Mr. Ganesh N. Nayak

Designation :

Director

Address :

3, Ashwamegh Part V, Jodhpur, Satelite Road, Ahmedabad – 380015, Gujarat, India

Date of Birth/Age :

18.05.1955

Date of Appointment :

24.01.2006

DIN No. :

00017481

 

 

Name :

Mr. Shirtishkumar G. Belapure

Designation :

Director

Address :

3, Amramanjari Bungalow, Opposite Chitvan Plor, Gala Club Road, Bopal – 380058, Gujarat, India

Date of Birth/Age :

19.07.1953

Date of Appointment :

16.07.2008

DIN No. :

02219458

Voter ID No.:

MT/09/045/107601

 

Name :

Mr. Arthur J. Flocco JR

Designation :

Director

Address :

305, Meadow Lake Lane, Lake Forest, Illionis IL60045, USA

Date of Birth/Age :

12.08.1957

Date of Appointment :

22.07.2009

DIN No. :

02634539

 

Name :

Richard John Davies

Designation :

Director

Address :

331, Sheridan Road, Winnetka IL U.S - 600934227

Date of Birth/Age :

26.06.1961

Date of Appointment :

02.05.2013

DIN No. :

06568148

 

 

Name :

Mr. Bhaktavatsala Canakapalli Rao

Designation :

Chairman cum Managing Director (w.e.f. 25.01.2011)

Address :

No. 9, Old No. 6, Lakshmanan Street, Mahalingapuram, Nungambakkam, Chennai – 600034, Tamilnadu, India

Date of Birth/Age :

10.08.1949

Date of Appointment :

15.04.2010

DIN No. :

00010175

 

 

Name :

Mr. Matthew Robert Stober

Designation :

Director

Address :

6848 Piershill Lane, Cary, NC - 27519, US

Date of Birth/Age :

20.06.1967

Date of Appointment :

11.02.2014

DIN No. :

06796590

 

 

Name :

Mr. Nitinkumar Dalsukhray Parekh

Designation :

Director

Address :

A-3, Aryaman Bungalows, Near Railway Crossing, Thaltej – Shilaj Road, Ahmedabad – 380015, Gujarat, India

Date of Birth/Age :

09.02.1961

Date of Appointment :

11.02.2014

DIN No. :

00155570

 

 

KEY EXECUTIVES

 

Name :

Mr. Umesh Vinodchandra Parikh

Designation :

Vice President-Finance and Company Secretary

Address :

B-7, Jineshwar Nagar Part-I, Near Gyanjyot School, Ranna Park, Ghatlodia, Ahmedabad – 380061, Gujarat, India

Date of Birth/Age :

27.05.1968

Date of Appointment :

17.11.2005

PAN No.:

ACCPP4496R

 

 

MAJOR SHAREHOLDERS

 

As on 01.08.2014

 

Names of Shareholders

 

No. of Shares

Hospira Australia Pty Limited, Australia

 

7500000

Cadila Healthcare Limited, India

 

7500000

 

 

 

Total

 

15000000

 

 

 

 

As on 01.08.2014

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

50.00

Bodies corporate

50.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Pharmaceutical Products.

 

 

Products :

Item Code No. (ITC Code)

Product Description

30049044

Docetaxel

30049049

Other Anticencer Formulation

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

 

Products :

Pharmaceutical Products

Countries :

  • USA
  • UK
  • Australia
  • Europe

 

 

Imports :

 

Products :

Raw Materials

Countries :

  • US
  • Europe
  • China
  • Singapore

 

 

Terms :

 

Selling :

Cash and Advance Payment (60 Days)

 

 

Purchasing :

Cash and Advance Payment (30/60 Days)

 

PRODUCTION STATUS = NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

 

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Experience :

Not Divulged

Maximum Limit Dealt :

Not Divulged

 

 

Customers :

 

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Experience :

Not Divulged

Maximum Limit Dealt :

Not Divulged

 

 

No. of Employees :

260  (Approximately)

 

 

Bankers :

Banker Name 1

ICICI Bank Limited

Branch Address

Alkapuri Branch

Person Name (With Designation)

Mr. Rumit Mehta (Regional Manager)

Contact Number

91-8128987978

Name of Account Holder

Zudus Hospira Oncology Private Limited

Account Number

Not Divulged

Account Since (Date/Year of Account Opening)

Not Divulged

Average Balance Maintained (If Possible)

Not Divulged

Credit Facilities Enjoyed (If any)

CC/L/C/OD = Rs. 600.000 Millions

Account Operation

Not Divulged

Remarks (If any)

Not Divulged

 

 

Banker Name 2

HSBC Bank

Branch Address

 Ahmedabad

Person Name (With Designation)

Not Divulged

Contact Number

Not Divulged

Name of Account Holder

Not Divulged

Account Number

Not Divulged

Account Since (Date/Year of Account Opening)

Not Divulged

Average Balance Maintained (If Possible)

Not Divulged

Credit Facilities Enjoyed (If any)

CC/L/C/OD = Rs. 100.000 Millions

Account Operation

Not Divulged

Remarks (If any)

Not Divulged

 

 

Banker Name 3

Standard Chartered Bank

Branch Address

Ahmedabad

Person Name (With Designation)

Not Divulged

Contact Number

Not Divulged

Name of Account Holder

Not Divulged

Account Number

Not Divulged

Account Since (Date/Year of Account Opening)

Not Divulged

Average Balance Maintained (If Possible)

Not Divulged

Credit Facilities Enjoyed (If any)

CC/L/C/OD = Rs. 300.000 Millions

Account Operation

Not Divulged

Remarks (If any)

Not Divulged

 

 

Banker Name 4

Bank of Baroda

Branch Address

Ahmedabad

Person Name (With Designation)

Not Divulged

Contact Number

Not Divulged

Name of Account Holder

Not Divulged

Account Number

Not Divulged

Account Since (Date/Year of Account Opening)

Not Divulged

Average Balance Maintained (If Possible)

Not Divulged

Credit Facilities Enjoyed (If any)

Not Divulged

Account Operation

Not Divulged

Remarks (If any)

Not Divulged

 

 

 

Auditors :

 

Name :

B S R and Company

Chartered Accountants

Address :

Lodha Excelus, 1st, Floor, Apollo mills compound, N M Joshi Marg, Mahalaxmi, Mumbai – 400011, Maharashtra, India

PAN No. :

AAAFB9852F

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Joint Ventures :

·         Cadila Healthcare Limited, Australia

CIN No: L24230GJ1995PLC025878

·         Hospira Australia Pty Limited, India

 

 

 

CAPITAL STRUCTURE

 

As on 01.08.2014

 

No. of Shares

Type

Value

Amount

 

 

 

 

15000000

Equity Shares

Rs.10/- each

Rs.150.000  Millions

5000

Preference Shares

Rs. 100000/- each

Rs.500.000  Millions

 

 

 

 

 

Total

 

Rs.650.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

15000000

Equity Shares

Rs.10/- each

Rs.150.000 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

 

SOURCES OF FUNDS

31.03.2014

31.03.2013

31.03.2012

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

150.000

150.000

150.000

(b) Reserves & Surplus

3088.810

2859.830

3088.550

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

3238.810

3009.830

3238.550

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

18.690

0.000

0.000

(c) Other long term liabilities

5.960

1.280

0.280

(d) long-term provisions

8.570

7.560

6.900

Total Non-current Liabilities (3)

33.220

8.840

7.180

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

245.330

113.550

142.120

(c) Other current liabilities

24.410

31.580

47.090

(d) Short-term provisions

1304.780

3952.650

104.150

Total Current Liabilities (4)

1574.520

4097.780

293.360

 

 

 

 

TOTAL

4846.550

7116.450

3539.090

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

656.520

646.020

685.770

(ii) Intangible Assets

6.120

7.090

8.930

(iii) Capital work-in-progress

501.610

113.010

28.690

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

565.530

77.610

32.440

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

1729.780

843.730

755.830

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

375.480

1596.330

60.780

(b) Inventories

1212.460

533.700

560.840

(c) Trade receivables

728.530

1298.450

1619.830

(d) Cash and cash equivalents

724.030

2816.690

526.290

(e) Short-term loans and advances

15.410

14.520

10.780

(f) Other current assets

60.860

13.030

4.740

Total Current Assets

3116.770

6272.720

2783.260

 

 

 

 

TOTAL

4846.550

7116.450

3539.090

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

Income

 

Other Income

 

 

 

 

TOTAL (A)

4549.960

6882.500

5928.200

 

 

 

 

 

Less

TOTAL  EXPENSES

1834.300

2151.350

1418.930

 

 

 

 

 

Less

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (C)

2715.660

4731.150

4509.270

 

 

 

 

 

Less

FINANCIAL EXPENSES (D)

0.000

0.000

21.470

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E)

2715.660

4731.150

4487.800

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION (F)

83.230

80.670

74.870

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX (E-F)   (G)

2632.430

4650.480

4412.930

 

 

 

 

 

Less

TAX (I)

34.300

930.620

870.170

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX  (G-I)   (J)

2598.130

3719.860

3542.760

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD  (K)

1442.110

2042.810

370.070

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

Transfer to General Reserve

259.810

371.980

354.280

 

Dividend

188.640

573.580

960.000

 

Tax on Dividend

1110.000

3375.000

155.740

 

Transfer to capital redemption reserves

0.000

0.000

400.000

 

Total (M)

1558.450

4320.560

1870.020

 

 

 

 

 

 

Balance Carried to the B/S (J+K+L-M)

1411.280

1442.110

2042.810

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

F.O.B. Value of Exports

2879.950

7032.240

7034.620

 

TOTAL EARNINGS

2879.950

7032.240

7034.620

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

173.21

247.99

236.18

 

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

(PAT/Sales)

(%)

57.10

54.05

59.76

 

 

 

 

 

Operating Profit Margin

(PBDIT / Sales)

(%)

0.00

0.00

76.06

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

60.59

66.40

125.71

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.81

1.55

1.36

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.98

1.53

9.49

 

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

150.000

150.000

150.000

Reserves & Surplus

3088.550

2859.830

3088.810

Net worth

3238.550

3009.830

3238.810

 

 

 

 

long-term borrowings

0.000

0.000

0.000

Short term borrowings

0.000

0.000

0.000

Total borrowings

0.000

0.000

0.000

Debt/Equity ratio

0.000

0.000

0.000

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Total Income

5928.200

6882.500

4549.960

 

 

16.098

(33.891)

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Total Income

5928.200

6882.500

4549.960

Profit

3542.760

3719.860

2598.130

 

59.76%

54.05%

57.10%

 

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

CURRENT MATURITY OF LONG TERM DEBT – NOT AVAILABLE

 

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

Yes

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

----------------------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

----------------------

22]

Litigations that the firm / promoter involved in

----------------------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------------------

26]

Buyer visit details

----------------------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

Yes

34]

External Agency Rating, if available

Yes

 

Note:

Registered office of the company has been shifted from Gandhi Nagar Highway, Ahmedabad – 380015, Gujarat, India India to the present address w.e.f.19.07.2007

 

 

BACKGROUND

 

The Company is a Joint Venture between Cadila Healthcare Limited and Hospira Australia Pty Limited, incorporated in Australia. The Company is manufacturing anti-cancer formulations in Pharmez, Special Economic Zone near Ahmedabad. The Company had started the commercial production on 1 May 2009.

 

 

INDEX OF CHARGES

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10518982

26/08/2014

600,000,000.00

ICICI Bank Limited

9th Floor, JMC House, Opp. Parimal Garden, Ambawadi, Ahmedabad, Gujarat - 380006, INDIA

C19737519

2

10211370

11/09/2014 *

300,000,000.00

Standard Chartered Bank

ABHIJEET II, NEAR MITHAKHALI CROSS ROADS, AHMEDABAD, Gujarat - 380006, INDIA

C22843486

 

* Date of charge modification

 

 

 

FIXED ASSETS

²  Land

²  Buildings

²  Plant and Equipment

²  Furniture and Fixtures

²  Vehicles

²  Office equipment

²  Computer Equipments

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.39

UK Pound

1

Rs.94.17

Euro

1

Rs.73.61

 

 

INFORMATION DETAILS

 

Information Gathered by :

SVA

 

 

Analysis Done by :

DIV

 

 

Report Prepared by :

ART


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

7

PAID-UP CAPITAL

1~10

7

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

7

--PROFITABILITY 

1~10

7

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

7

--RESERVES

1~10

7

--CREDIT LINES

1~10

7

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

YES

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

63

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.